Results 141 to 150 of about 4,101 (195)

Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma. [PDF]

Oncotarget, 2022
Villa NY, Rahman MM, Mamola J, Sharik ME, de Matos AL, Kilbourne J, Lowe K, Daggett-Vondras J, D'Isabella J, Goras E, Chesi M, Bergsagel PL, McFadden G.   +12 more
europepmc   +1 more source

New threat to the brown hare: Iberian myxoma virus variant detected in Germany for the first time

An increasing number of seriously ill or dead brown hares (Lepus europaeus) are currently being observed in North Rhine-Westphalia, Germany. The animals showed typical signs of myxomatosis (rabbit plague) such as swollen eyelids, genital mucous membranes

core  

Oncolytic myxoma virus and engineering strategies for advanced cancer immunotherapy. [PDF]

iScience
Trujillo Yeriomenko AD, Isaeva AS, Idota EE, Zhivoderov SP, Yurkov SG, Malogolovkin AS.   +5 more
europepmc   +1 more source

RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells. [PDF]

J Virol, 2021
Rahman MM, Gutierrez-Jensen AD, Glenn HL, Abrantes M, Moussatche N, McFadden G.   +5 more
europepmc   +1 more source

Testing Oncolytic Myxoma Virus in Immunocompetent Mouse Model for Cancer Therapy. [PDF]

Methods Mol Biol
Shakiba Y, Rahman MM.
europepmc   +1 more source

Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib. [PDF]

Oncolytic Virother, 2020
Ashton LV, Graham B, Afzali MF, Gustafson D, MacNeill AL.   +4 more
europepmc   +1 more source

Development of two indirect ELISAs using purified recombinant viral proteins to detect myxoma virus-antigen specific antibodies in rabbit sera. [PDF]

BMC Vet Res
Calonge-Sanz I, Casais R, Nicieza I, Vicente SA, Dos Santos FAA, Martín-Alonso JM, Domínguez P, Álvarez AL, Duarte MD, Parra F, Dalton KP.   +10 more
europepmc   +1 more source

Arming vaccinia virus for pancreatic cancer oncolytic virotherapy

, 2011
PhDVaccinia virus is a 250-300nm enveloped DNA virus from the poxvirus family and is used as a vector for oncolytic viral gene therapy. No unique cell surface receptor has been identified for Vaccinia virus and the reasons for its tropism for cancer ...
Hiley, Crispin
core  

NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy. [PDF]

Oncotarget, 2020
Cornejo Y, Li M, Dellinger TH, Mooney R, Rahman MM, McFadden G, Aboody KS, Hammad M.   +7 more
europepmc   +1 more source

Identification and Characterisation of a Myxoma Virus Detected in the Italian Hare (Lepus corsicanus). [PDF]

Viruses
Rossini E, Bazzucchi M, Trocchi V, Merzoni F, Bertasio C, Knauf S, Lavazza A, Cavadini P.   +7 more
europepmc   +1 more source